Project Details
Description
ATB200-03: A PHASE 3 DOUBLE-BLIND RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF INTRAVENOUS ATB200 CO-ADMINISTERED WITH ORAL AT2221 IN ADULT SUBJECTS WITH LATE ONSET POMPE DISEASE COMPARED WITH ALGLUCOSIDASE ALFA/PLACEBO
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/19 → 12/31/20 |
Funding
- AMICUS THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.